BioSpace News Archive

The global dermatology devices market is expected to grow at a significant pace in the coming years.

ERYTECH Pharma announced the acceptance of an abstract with the results of its expanded access program evaluating eryaspase in acute lymphoblastic leukemia for poster presentation at the upcoming 2021 American Society of Hematology Annual Meeting, which will be held from December 11-14, 2021, both inAtlanta, Georgiaand virtually.

Masimo announced the findings of a prospective study published in Frontiers in Neurology in which Dr. Na Xu and colleagues at Capital Medical University in Beijing investigated whether general anesthesia guided by Masimo SedLine® Brain Function Monitoring parameters on Root® could reduce the incidence of postoperative delirium in patients undergoing carotid endarterectomy.

ANGLE plc a world-leading liquid biopsy company, announces the appointment of Todd Druley, M.D., PhD. in the newly created role of Chief Medical Officer, based in the United States.

Emmes today announced a partnership with MedGenome aimed at accelerating breakthrough treatments, powered by human genomics, for rare disease patients.

Mainz Biomed N.V., a molecular genetics diagnostic company specializing in the early detection of cancer, is pleased to announce that Company representatives will be attending MEDICA 2021 to showcase ColoAlert, its highly efficacious and easy-to-use diagnostic test for colorectal cancer.

Orthogon Therapeutics LLC, a drug development company focused on designing innovative antivirals and anti-infective therapeutics, announced that it has appointed Dr. Marie Lindner as an independent director to its board of directors.

BiondVax Pharmaceuticals Ltd. announced that Chief Executive Officer Amir Reichman will present a company overview at the H.C. Wainwright 7th Annual Israel Virtual Conference Nov. 15, 2021 at 10:30 am ET.

Aditum Bio, the biotech investment firm co-founded in 2019 by former Novartis CEO Joe Jimenez and former President of the Novartis Institutes for BioMedical Research Dr. Mark Fishman, announced the formation of Motric Bio, a portfolio company developing a new therapy for spasticity associated with neurological injuries and disease.

According to the report, the global X-ray detectors market was valued at US$ 2.5 Bn in 2020 and is projected to expand at a moderate CAGR from 2021 to 2031.